📑Antineovaskuliarizuojantys vaistai (Aflibercept) amzines geltonosios demes gydymui.
Procurement process summary
This process is to purchase Antineovaskuliarizuojantys vaistai (Aflibercept) amzines geltonosios demes gydymui.
This contract was awarded by 🇱🇹 Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos for an amount of EUR 480,240 to 1 supplier. It was published on 2017-03-15 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇱🇹 Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos Buying unitnot reported Publication date2017-03-15 Contest statusnot reported DescriptionAntineovaskuliarizuojantys vaistai (Aflibercept) amzines geltonosios demes gydymui.Awards
This award was granted to UAB „Bayer“ by Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos for an amount of EUR 480,240. The procurement process was conducted through open for the category of goods. The award was granted on 2017-02-23. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇱🇹 UAB „Bayer“ | EUR 480,240 | 2017-02-23 | 1 |
Market context and opportunities
The execution of this contract allows the entity Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberLT_ocds-70d2nz-bcc981fa-a833-4fb4-85b8-54b2e9be915d-award-1Publication date2017-03-15Contract datenot reportedAward date2017-02-23CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
